Literature DB >> 33786244

Chordoid Glioma With Dot-Like Immunoreactivity for Synaptophysin.

Ashley Rose Scholl1, Layla Nasr2, Cesar A Serrano3, Rudy J Castellani1.   

Abstract

Chordoid gliomas arise near the third ventricle and commonly present around 40 years of age. These rare tumors are non-invasive and often present with headaches and visual disturbances. Contrast enhancement on MRI is typical for these tumors and immunohistochemical (IHC) staining is positive for glial fibrillary acidic protein (GFAP). Surgical resection is the treatment of choice. We present this case of chordoid glioma because of its unique characteristics. The tumor lacked contrast enhancement on MRI and demonstrated juxtanuclear dot-like immunoreactivity for synaptophysin which is a feature not previously reported in the literature. It is important for pathologists and radiologists to be on the lookout for atypical presentations of these rare tumors.
Copyright © 2021, Scholl et al.

Entities:  

Keywords:  chordoid glioma; contrast enhancement; synaptophysin; third ventricle

Year:  2021        PMID: 33786244      PMCID: PMC7997551          DOI: 10.7759/cureus.13537

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  6 in total

1.  Origin of chordoid glioma of the third ventricle.

Authors:  Norman E Leeds; Frederick F Lang; Teresa Ribalta; Raymond Sawaya; Gregory N Fuller
Journal:  Arch Pathol Lab Med       Date:  2006-04       Impact factor: 5.534

2.  Chordoid gliomas of the third ventricle share TTF-1 expression with organum vasculosum of the lamina terminalis.

Authors:  Franck Bielle; Chiara Villa; Marine Giry; Anne-Marie Bergemer-Fouquet; Marc Polivka; Alexandre Vasiljevic; Marie-Hélène Aubriot-Lorton; Michèle Bernier; Emmanuèle Lechapt-Zalcman; Gabriel Viennet; Véronique Sazdovitch; Charles Duyckaerts; Marc Sanson; Dominique Figarella-Branger; Karima Mokhtari
Journal:  Am J Surg Pathol       Date:  2015-07       Impact factor: 6.394

Review 3.  The trans-laminar terminalis approach reduces mortalities associated with chordoid glioma resections: A case report and a review of 20 years of literature.

Authors:  C W Huo; V Rathi; A Scarlett; J Galanos; Y Y Wang
Journal:  J Clin Neurosci       Date:  2017-10-21       Impact factor: 1.961

Review 4.  Chordoid glioma of the third ventricle: a patient presenting with SIADH and a review of this rare tumor.

Authors:  Matilde Calanchini; Simon Cudlip; Monika Hofer; James Byrne; Andrea Fabbri; Ashley Grossman
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

Review 5.  Third ventricular chordoid glioma: case report and review of the literature.

Authors:  Masayuki Nakajima; Satoshi Nakasu; Naoki Hatsuda; Yasuhiro Takeichi; Kazuyoshi Watanabe; Masayuki Matsuda
Journal:  Surg Neurol       Date:  2003-05

6.  A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle.

Authors:  Benjamin Goode; Gourish Mondal; Michael Hyun; Diego Garrido Ruiz; Yu-Hsiu Lin; Jessica Van Ziffle; Nancy M Joseph; Courtney Onodera; Eric Talevich; James P Grenert; Iman H Hewedi; Matija Snuderl; Daniel J Brat; Bette K Kleinschmidt-DeMasters; Fausto J Rodriguez; David N Louis; William H Yong; M Beatriz Lopes; Marc K Rosenblum; Nicholas Butowski; Tarik Tihan; Andrew W Bollen; Joanna J Phillips; Arun P Wiita; Iwei Yeh; Matthew P Jacobson; Boris C Bastian; Arie Perry; David A Solomon
Journal:  Nat Commun       Date:  2018-02-23       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.